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Background. We investigated cerebral structural connectivity and its relationship to symptoms in never-medicated
individuals with first-onset schizophrenia using diffusion tensor imaging (DTI).
Method. We recruited subjects with first episode DSM-IV schizophrenia who had never been exposed to
antipsychotic medication (n=34) and age-matched healthy volunteers (n=32). All subjects received DTI and
structural magnetic resonance imaging scans. Patients’ symptoms were assessed on the Positive and Negative
Syndrome Scale. Voxel-based analysis was performed to investigate brain regions where fractional anisotropy (FA)
values significantly correlated with symptom scores.
Results. In patients with first-episode schizophrenia, positive symptoms correlated positively with FA scores in
white matter associated with the right frontal lobe, left anterior cingulate gyrus, left superior temporal gyrus, right
middle temporal gyrus, right middle cingulate gyrus, and left cuneus. Importantly, FA in each of these regions
was lower in patients than controls, but patients with more positive symptoms had FA values closer to controls.
We found no significant correlations between FA and negative symptoms.
Conclusions. The newly-diagnosed, neuroleptic-naive patients had lower FA scores in the brain compared with
controls. There was positive correlation between FA scores and positive symptoms scores in frontotemporal tracts,
including left fronto-occipital fasciculus and left inferior longitudinal fasciculus. This implies that white matter
dysintegrity is already present in the pre-treatment phase and that FA is likely to decrease after clinical treatment or
symptom remission.
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Introduction
Diffusion tensor imaging (DTI) is a novel research
approach to assess the amount and preferred direction
of diffusion of water molecules in vivo (Basser et al.
1994 ; Basser, 1995). In the brain, water molecules tend
to diffuse along the direction of the axonal fibres
wrapped by myelin sheathes ; thus, DTI serves as a
proxy measure of the orientation and structure of
white matter comprising millions of axonal fibres
grouped together in myelinated sheaths (Basser, 1995).
Fractional anisotropy (FA) is a measure of the di-
rectional diffusion of water, values range from 0
(completely anisotropic or randomly directed) to 1
(completely isotropic or uni-directional). FA scores
increase in healthy children with better reading and
spelling skills (Deutsch et al. 2005) and cognitive per-
formance (Schmithorst et al. 2005) and decrease in
adults with multiple sclerosis (Horsfield et al. 1998),
traumatic brain injury (Gupta et al. 2005) and normal
and abnormal ageing (Moseley, 2002). This makes it a
useful tool to detect and quantify dynamic changes
in white matter microstructure during neurodevel-
opment and degeneration of the brain. Since
schizophrenia can be regarded as a disorder of neu-
rodevelopment (Bullmore et al. 1997 ; Rapoport et al.
2005), DTI presents a safe and convenient tool to study
how brain connectivity in patients differs from healthy
individuals.
Using DTI, our group was the first to report wide-
spread white matter disruption in individuals newly
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diagnosed with schizophrenia prior to treatment with
antipsychotic medication (Cheung et al. 2008). We
found that a range of white matter FA decreases ad-
jacent to frontotemporal and striatolimbic regions in
patients relative to healthy controls. Almost without
exception, we and other groups have reported lower
FA in patients compared with healthy controls
(Kanaan et al. 2009). Most often implicated are the
prefrontal and temporal lobes (Ardekani et al. 2003 ;
Szeszko et al. 2005 ; Ellison-Wright & Bullmore, 2009)
and their interconnecting white matter tracts : uncinate
fasciculus ; cingulum bundle (Kubicki et al. 2003, 2005 ;
Sun et al. 2003 ; Hubl et al. 2004 ; Zetzsche et al. 2007) ;
arcuate fasciculus (Hubl et al. 2004 ; Kubicki et al.
2005) ; inferior longitudinal fasciulus (Ashtori et al.
2007) (for a review, see Kanaan et al. 2005, 2009 ;
Kubicki et al. 2007 ; Kyriakopoulos et al. 2008). We
also reported lower FA in the splenium of the corpus
callosum (Cheung et al. 2008) and previous groups
have also described reduced diffusivity in this princi-
pal interhemispheric tract (Foong et al. 2000, 2002 ;
Ardekani et al. 2003 ; Hubl et al. 2004 ; Kalus et al. 2005)
as well as in the striatum (Hubl et al. 2004 ; Kubicki
et al. 2005, Szeszko et al. 2005) and the hippocampal/
parahippocampal region (Ardekani et al. 2003 ; Kalus
et al. 2004, 2005).
Few studies have examined the relationship be-
tween white matter connectivity and symptoma-
tology. Hubl et al. (2004) first explored this by
comparing 13 chronically auditorily hallucinating
patients with 13 non-auditorily hallucinating patients
and 13 healthy controls. They reported significantly
higher FA scores in the hallucinators versus the other
two groups in the lateral parts of the temporo-parietal
section of the arcuate fasciculus and in parts of
the anterior corpus callosum. The lateral part of the
arcuate fasciculus links Broca’s area in the frontal lobe
to Wernicke’s area in the temporal lobe and is dis-
rupted in aphasia. The hallucinating group also had
greater FA than the non-hallucinating group in the
left cingulum bundle, which may represent aberrant
emotional circuitry. Others have failed to replicate
these results. Seok and co-workers, in a group of like-
wise intractably hallucinated patients as compared
with non-hallucinators and healthy controls, found
only a positive correlation between severity of audi-
tory hallucinations and FA score in the left frontal part
of the superior longitudinal fasciculus (Seok et al.
2007). Fujiwara and co-workers also used DTI based
on a region-of-interest analysis restricted to the
anterior and posterior cingulate bundles and found
that positive symptoms in chronically psychotic
patients were positively correlated with FA scores
in the posterior cingulate bundle (Fujiwara et al. 2007).
In contrast, Skelly and co-workers used voxel-based
DTI to show lower FA in 25 patients with chronic
schizophrenia compared with 25 healthy controls.
They reported that positive symptoms were inversely
correlated with FA scores in diverse regions, including
the left uncinate fasciculus, right sagittal striatum
and left superior longitudinal fasciculus (Skelly et al.
2008).
Thus, there is discrepancy in the literature and it
may be useful to clarify the direction of the relation-
ship between white matter FA and symptom severity
using a first-episode sample. A handful of DTI studies
have recruited such patients (Price et al. 2007a, b ;
Cheung et al. 2008 ; Friedman et al. 2008 ; Peters et al.
2008) and while there have been negative findings
(Friedman et al. 2008 ; Peters et al. 2008), others noted
deep frontotemporal white matter connections
(Kyriakopoulos et al. 2008), especially the inferior
fronto-occipital fasciculus (Ellison-Wright & Bullmore,
2009), uncinate fasciculus (Price et al. 2007b) as well as
callosum (Price et al. 2007a ; Kyriakopoulos & Frangou,
2009) and cerebellar tracts (Kyriakopoulos & Frangou,
2009). These findings appear weaker than those
described above in chronic populations, in which
dose-dependent FA increase may have contributed
(Okugawa et al. 2004 ; Shergill et al. 2007). The tend-
ency to step up medication afflicts chronically
relapsing samples and this in turn can confound
the interpretation of results (Kanaan et al. 2005 ;
Kyriakopoulos et al. 2008). In addition, the issue of
sample size and heterogeneity in data processing
(Zetzsche et al. 2007 ; Ellison-Wright & Bullmore,
2009) may have contributed to inconsistencies across
studies. For example, antipsychotic medication can
increase basal ganglia volume (Chakos et al. 1994 ;
Sigmundsson et al. 2001; Chua et al. 2008 ; Deng et al.
2009 ; Leung et al. 2009) and even just a few days of
antipsychotic treatment can modulate FA (Kanaan
et al. 2009). Therefore, we conceived a study to address
the role of symptoms on white matter organization in
a voxel-by-voxel basis in patients presenting for the
first time with schizophrenia, who had never pre-
viously been exposed to antipsychotic medication. The
aim of the study is to address the issues of chronicity
and medication exposure as potential confounders.
We sought to limit their effect by ensuring that our
sample consists of individuals newly diagnosed with
schizophrenia presenting in their first episode of ill-
ness and all neuroleptic-naive.
Method
Subjects
All subjects recruited were aged between 18 and
45 years. They had 6–18 years of education, were
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Chinese and had given fully informed written consent
to participate in a study approved by the Hong Kong
West Cluster Institutional Review Board of the hospi-
tal. Subjects were excluded if they had a history of
neurological illness (such as epilepsy, strokes or
meningitis), head injury that required hospitalization,
persistent headaches, genetic disorder (such as tuber-
ous sclerosis, fragile X syndrome), electroconvulsive
therapy, history of drug and/or alcohol abuse, hyper-
activity, mental retardation, suspension from school
for >6 months. They were also excluded if they had
taken medication for any chronic medical condition in
the previous week.
Patients were recruited from the teaching hospital
of The University of Hong Kong. Inclusion criteria
were no previous antipsychotic treatment, first
experience of psychotic symptoms (i.e. hallucinations,
and/or delusions and/or thought disorder), no sig-
nificant mood/organic disorder, with decline in daily
functioning and fulfilling criteria for a diagnosis of
DSM-IV schizophrenia (APA, 1994) after assessments
by specialist clinician investigators in psychiatry
(C.P.Y.C., C.W.L.). Healthy controls from the local
community were recruited by advertisement.
Patients were screened on the first day of presen-
tation to hospital and gave full informed written con-
sent to participate. Symptoms were rated by a
specialist psychiatrist with clinical responsibility for
the care of the patients using the Positive and Negative
Syndrome Scale (PANSS; Kay et al. 1987, 1988), with
intra-class correlation coefficients 0.73–0.83 (Chen et al.
2005) based on a 30-item scale with positive, negative
and general psychopathology items demonstrating
high reliability and validity (Kay et al. 1988 ; Kay,
1990). A magnetic resonance imaging (MRI) scan was
performed according to the protocol below before
initiating antipsychotic medication.
MRI data acquisition
DTI and T2/PD datasets were acquired by GE Signa
1.5 T system (General Electric, USA). A 5-min DTI se-
quence followed the protocol of Leung et al. (2004) and
comprised single-shot spin-echo echo-planar imaging
with TR=10 000 ms, TE=100 ms, acquisition matrix=
128r128, and field of view=28 cm, slice thickness of
5- with 1.5 mm gap. In total, 25 volumes had diffusion-
sensitizing gradient encoding (Basser et al. 1994 ;
Basser, 1995) applied along 25 directions with a
diffusion-weighted factor b=1200 s/mm2 and one
volume, B0, without a diffusion gradient, b=0 s/mm2
(see Cheung et al. 2008). A dual-echo fast spin echo
sequence provided T2/PD datasets aligned to AC-PC
across the whole brain, 3 mm thick, Nex=0, TR 5–6 s,
TE 20/80 ms, matrix 256r192 (see McAlonan et al.
2005).
Imaging processing and analysis
Image pre-processing was performed using SPM2
(Wellcome Department of Cognitive Neurology,
Institute of Neurology, UK) and the Diffusion II tool-
box (http://sourceforge.net/projects/spmtools) run-
ning in MATLAB 6.5 (The MathWorks, Inc., USA). The
DTI pre-processing sequence was based upon the op-
timized voxel-based morphometric approach of Good
et al. (2001) and Cheung et al. (2008).
To examine the relationship between symptoms and
FA, whole brain FA maps of the patient group were
correlated separately with positive and negative
PANSS scores in a voxel-by-voxel manner using a
standard linear regression model (Genovese et al.
2002) with results thresholded at a false discovery rate
(FDR) of p<0.05 (two tailed, corrected). As in our
previous study (Cheung et al. 2008), we used the FDR
threshold of p<0.05 (two tailed, corrected), where
FDR is the proportion of false positives (incorrect re-
jections of the null hypothesis) among those tests for
which the null hypothesis is rejected (Genovese et al.
2002). We relied upon the FDR method to control for
multiple comparisons leading to type 1 error under
the null hypothesis (Bullmore et al. 1999) as opposed to
the Bonferroni correction, which is regarded as overly
strict, where neighbouring pixels are interdependent
(Genovese et al. 2002). All MNI coordinates were con-
verted to Talairach using a standard non-linear algor-
ithm (Brett, 2002).
Results
Subjects with schizophrenia (n=34) had a mean age of
25.4 (S.D.=7.5) years. There were 17 females, who were
all right-handed. They had a PANSS positive symp-
tomatology mean score of 19.9 (S.D.=4.2), PANSS
negative symptomatology mean score of 15.0 (S.D.=
7.2). The healthy controls had a mean age of 27.6
(S.D.=8.5) years and did not differ significantly from
the patients (p>0.03), 15 were female and all were
right-handed and did not differ significantly with the
patients (p=0.9). In this study, all subjects were right-
handed and are extended from a previous sample
(25 patients, 26 healthy controls) from Cheung et al.
(2008).
Voxel-wise correlation of FA scores and PANSS
In total, 34 never-medicated patients with first-episode
schizophrenia and 32 healthy controls successfully
underwent a MRI scan. Altogether, 31 patients with
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never-medicated first-episode schizophrenia who had
PANSS data for positive and negative PANSS scores
were entered into the analysis. We then compared
all 34 patients with the 32 healthy controls on mean
FA values for 11 clusters that showed significant cor-
relation with PANSS scores (Table 1).
We found that FA values in 11 frontal (Figs 1 and 2)
and temporal-limbic (Figs 1 and 3) clusters were
positively associated with high positive symptom
scores [voxel level p<0.05 (FDR-corrected), cluster
size 100, cluster level p<0.05 (uncorrected)]. Notwith-
standing this, for all 11 clusters, the FA values were
lower in patients than in healthy controls, significantly
so around the left anterior cingulate and superior
temporal regions (see Table 1). Thus, the closer FA
values in the patient group were to control measures,
the greater the number of positive symptoms. There
were no brain regions showing negative correlation
with positive PANSS. There were also no brain regions
showing any correlation with negative PANSS.
Discussion
Our principal finding is that in antipsychotic-naive
patients newly diagnosed with schizophrenia, positive
symptoms showed a significant positive correlation
with widespread regions, including fronto-occipital
and temporo-limbic white matter FA scores. Speci-
fically, these regions included the right frontal lobe,
left anterior cingulate gyrus, left body of cingulum, left
superior temporal gyrus, right middle temporal gyrus,
right inferior parietal gyrus, left cuneus, left genu of
corpus callosum, right extension of posterior internal
capsule. However, in all of these regions FA scores
were lower in patients than healthy controls. Our
present study extends our previous DTI work on
never-medicated patients in their first episode of
schizophrenia (Cheung et al. 2008), indicating that
patients with FA values approaching control levels in
fronto-occipital and temporo-limbic tracts have the
greatest number of positive symptoms.
In our previous study (Cheung et al. 2008), we re-
ported decreased FA in patients compared with heal-
thy controls in a widespread pattern, which included
the fronto-occipital and temporo-limbic regions cor-
responding to the left fronto-occipital fasciculus and
inferior longitudinal fasciculus, white matter adjacent
to right precuneus, splenium of corpus callosum, right
posterior limb of internal capsule, white matter adjac-
ent to right substantia nigra and left cerebral peduncle.
The current study found that, despite lower FA in the
patient group relative to controls, there was a positive
correlation between positive symptoms and FA en-
compassing a widespread network including fronto-
occipital and temporo-limbic pathways. This result
may be considered rather counter-intuitive in that
more florid positive symptoms of schizophrenia are
associated with white matter FA values very similar to
control levels. We note that FA relatively increased
with positive symptoms even though, overall, the ab-
solute FA scores were all lower in the group with
schizophrenia.
Widespread cortical thinning has been described
both in first-episode schizophrenia in the frontopolar,
cingulate and occipital regions (Narr et al. 2005). The
same group had earlier reported that very early onset
individuals followed up over 5 years showed striking
grey matter loss originating in the parietal cortex
dynamically moving to temporal then frontal cortices
(Thompson et al. 2001). They noted that this grey
matter loss correlated with psychotic symptom sev-
erity as well as sensorimotor (including visuo-spatial
and auditory functions) and executive function im-
pairments (Thompson et al. 2001). Cortical thinning is
believed to reflect underlying reduced neuropil and
neuronal size with alterations in synaptic, dendritic
and axonal organization (Harrison, 1999) and, if pro-
gressive, may imply that dyconnectivity gets worse
over time. Hence, our data in newly diagnosed and
never-medicated subjects with schizophrenia support
the position that there is already widespread cortical
dysconnectivity with lower FA scores in patients
compared with controls across the board.
When we examined the overlap in spatial distri-
bution of ‘signature ’ between our previous study
(Cheung et al. 2008) and the current one, we noted that
three regions in the present study overlapped with
the previous one, in which seven regions had been
reported. All showed significantly reduced FA in
patients as compared with controls. These three re-
gions in the present study are left anterior cingulate
gyrus (anterior to fronto-occipital fasciculus), left
superior temporal gyrus (adjacent to inferior longi-
tudinal fasciculus) and right extension from posterior
limb of internal capsule. Since these regions are
dopamine-rich, we believe that they resonate with
the propensity for antipsychotics to modulate positive
symptoms and may be evidence of state- rather than
trait-related dysconnectivity. Hubl et al. (2004) had
reported higher white matter directionality in the
temporo-parietal region in auditorily hallucinated
patients versus non-auditorily hallucinated controls.
Other studies have also reported findings in this di-
rection (Fujiwara et al. 2007 ; Seok et al. 2007), although
they are not directly comparable to ours since all as-
sessed chronically ill patients with persistent symp-
toms and possibly lengthy exposure to antipsychotics.
Our findings are in keeping with those from three re-
cent DTI studies, which have also reported a positive
correlation between positive symptoms and FA.
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Table 1. White matter fractional anisotropy (FA) differences in patients compared with healthy controls
Brain regionsa showing significant correlation
with symptoms
Cluster
p value
Cluster size
(voxel)
Talairach coordinates (mm)
Voxel
Z valueb
FA mean (S.D.)
x y z Control (n=32) Patient (n=34)
Positive correlation with positive PANSS scores
Frontal lobe
R pre-central sulcus
(above arcuate/superior longitudinal fasiculus)
0.028 400 34 5 27 4.55 0.2988 (0.029) 0.2929 (0.037) N.S.
R post-central gyrus
(adjacent to fronto-occipital fasciculus)
<0.0005 1770 23 35 16 4.47 0.3250 (0.025) 0.3132 (0.038) N.S.
R inferior frontal gyrus
(fronto-occipital fasciculus)
0.016 751 16 30 1 3.78 0.4312 (0.036) 0.4187 (0.048) N.S.
L body of cingulum
(adjacent to fronto-occipital fasciculus)
0.001 1114 x15 2 29 4.45 0.3667 (0.030) 0.3635 (0.053) N.S.
L anterior cingulate gyrus
(anterior to fronto-occipital fasciculus)
0.004 784 x19 38 12 4.02 0.3699 (0.031) 0.3398 (0.041) *
Temporo-parietal
R middle temporal gyrus
(adjacent to inferior longitudinal fasciculus)
0.007 649 45 x50 4 4.05 0.3641 (0.051) 0.3421 (0.062) N.S.
L superior temporal gyrus
(adjacent to inferior longitudinal fasciculus)
0.016 498 x38 x33 6 3.63 0.3699 (0.050) 0.3398 (0.058) **
R inferior parietal gyrus 0.038 349 29 x31 37 3.53 0.3662 (0.030) 0.3584 (0.052) N.S.
Occipital
L cuneus 0.006 703 x19 x75 16 3.99 0.3117 (0.025) 0.2987 (0.047) N.S.
Subcortical
L genu of corpus callosum 0.030 392 x5 18 21 3.92 0.3551 (0.041) 0.3477 (0.057) N.S.
R extension from posterior internal capsule to central
sulcus, along fronto-occipito fasciculus
0.010 594 18 x5 22 4.61 0.3617 (0.039) 0.3447 (0.052) N.S.
PANSS, Positive and Negative Syndrome Scale ; R, right ; L, left ; N.S., non-significant group difference in mean FA.
a Brain regional labels are suggested for guidance only.
b p<0.05 (false discovery rate-corrected).
* Significant group difference in mean FA; p<0.05, uncorrected.
** Significant group difference in mean FA; p<0.005, uncorrected.
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Delusions/hallucinations positively correlated with
FA in the left inferior fronto-occipital fasciculus
(Szeszko et al. 2008). A positive correlation was also
noted between delusions of passivity and FA in the
frontocingulate region (Sim et al. 2009) and between
auditory hallucinations with FA in the arcuate/
superior longitudinal fasciculi and anterior cingulum
(Shergill et al. 2007). These sites of white matter dys-
connectivity are extensive (for review, see Catani et al.
2002), comprising the inferior fronto-occipital tract
(connects the frontal cortex with posterior temporal
and occipital cortex), the superior longitudinal fascu-
lus (links the frontal with parietal and temporal
cortices, the cingulum (joins the inferior temporal pole
with the subrostral frontal lobe, cingulate gyrus and
genu of corpus callosum). We believe that this myriad
of white matter deficits is in keeping with evidence
in the literature of established cortical thinning in
first-episode, minimally treated (Narr et al. 2005), as
well as very early onset, schizophrenia (Thompson
et al. 2001). Conceivably, some discrepancy in the ex-
tant literature may arise from sample characteristics,
such as effects of medication and chronicity, since
these are difficult to disentangle from pathology. For
example, of the three studies cited above, the Szeszko
group included the youngest patients (mean age=25
years), who were newly diagnosed but many already
in receipt of medication. They noted that medication
effects are still not well understood but that FA scores
inversely correlated with the duration of antipsychotic
treatment in the left superior longitudinal fasciculus
(Szeszko et al. 2008). Our study was conducted with
neuroleptic-naive individuals and our findings, taken
with these recent studies, argue for the presence of
frontotemporo-limbic dysconnectivity. This parsi-
monious interpretation is also propounded in a recent
meta-analysis by Ellison-Wright & Bullmore (2009).
However, for patients on treatment it is worth bearing
in mind the possible contribution from neuroleptic
treatment, since there is a duration- (Szeszko et al.
2008) and dosage- (Okugawa et al. 2004) dependent
relationship between antipsychotic treatment and FA
score. Our finding that positive symptoms are posi-
tively correlated with FA appears at odds with the
study by Skelly et al. (2008). The latter group reported
that chronically treated patients (mean age=34 years)
had lower brain FA in association tracts (including left
superior longitudinal fasciculus), which inversely
correlated with positive symptoms. This discrepancy
with our own results deserves to be carefully ad-
dressed. One possibility is that younger patients with
minimal or no exposure to medication experience FA
lowering further over time, i.e. an inverse relationship
with positive symptoms may emerge as the illness
progresses or as a consequence of medication ex-
posure (Szeszko et al. 2008). However, as our study
was cross-sectional, we anticipate that a future longi-
tudinal follow-up of our patients would be an ideal
approach to try to reconcile results from samples of
patients at different stages of illness.
Our cross-sectional analysis cannot speak to ‘cau-
sal ’ mechanisms but does prompt some interpretation.
Mild variation in FA may not reflect serious pathology
in neurotypical individuals but here potentially re-
veals vulnerability in those with psychosis. For ex-
ample, positive symptoms could be generated via
aberrant activation of white matter pathways, which
remain reasonably ‘ intact ’. Classically, symptoms in
schizophrenia aggregate into distinct symptom com-
plexes, suggesting that a distinct neural substrate
can be investigated by neuroimaging (Buchanan &
Carpenter, 1997). ‘Positive ’ symptoms (hallucinations,
delusions, thought disorder) are thought to reflect
+2
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+39
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Fig. 1. Functional anisotropy (FA) score correlates of
positive symptoms in schizophrenia. Red clusters show
significant positive correlations of white matter FA with
positive symptom scores in never-medicated patients with
first-episode schizophrenia (n=31). There were no significant
negative correlations of white matter FA with negative
symptom scores. The maps are orientated with the right
side of the brain shown on the right side of the panel. The
z coordinate for each axial slice in the standard space of
Talairach and Tournoux is given in mm.
1714 V. Cheung et al.
‘ state ’ and are more treatment-responsive (Buchanan
& Carpenter, 1997), ‘negative ’ symptoms represent
‘ trait ’ (Buchanan & Carpenter, 1997) and are regarded
as having a likely brain structural basis (Crow, 1985).
Persistently untreated positive (Flaum et al. 1995 ;
Sumich et al. 2005) or negative (Chua et al. 1997 ; Wible
et al. 2001) symptoms may well increase the likelihood
of brain structural abnormality but, at first episode, the
extent of white matter pathophysiology is still limited.
We cautiously suggest that our results indicate that
such limited brain structural pathology at first pres-
entation might provide a substrate for expression of
positive symptoms, characteristic of the early phase of
illness. There is some evidence to support this in the
literature. For example, the duration of untreated ill-
ness is associated with worse prognosis (Barnes et al.
2008) and more extensive brain structural differences
(Lappin et al. 2006). Positive symptoms are less
prominent over time (Arndt et al. 1995) and, with each
relapse, prognosis worsens and treatment dosages of-
ten escalate (Lieberman et al. 1993). Our data concur
with others (Hubl et al. 2004 ; Fujiwara et al. 2007 ;
Seok et al. 2007), which imply that disease progression
and symptomatology are related to changes in the or-
ganization of white matter circuitry. The corollary of
our finding of a positive correlation between FA scores
and positive symptoms in the left fronto-occipital and
temporo-limbic tracts is that, over time (as symptoms
abate with treatment), FA may decline and this
can represent a marker for treatment or prognosis.
Addressing this question in a longitudinal follow-up
study may help to determine the extent to which
positive and negative symptoms reflect white matter
pathology and whether FA can serve as a marker for
treatment or prognosis. Perhaps one way forward
would be to evaluate future treatment outcome based
on symptoms and/or functioning at 1 year or 2, and
then to enter this as covariate into the baseline scan in
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R pre-central sulcus 
R post-central gyrus 
R2 = 0.085, R Inferior Frontal gyrus
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Fig. 2. Scatter plot of the relationship between functional anisotropy (FA) of significant frontal clusters with positive symptom
subscale on the Positive and Negative Syndrome Scale (PANSS). A best-fitted least square line was plot for each of the five
frontal areas and their corresponding R2 given next to each of the best-fitted lines.
Symptoms and DTI in never-medicated first episode schizophrenia 1715
order to determine if baseline FA score may be used to
help predict future outcome.
The brain pathology in schizophrenia is suggested
to arise from dysregulation of the normal dendritic
organization that accompanies a critical surge in white
matter growth from adolescence to early adulthood
(Sowell et al. 1999), when prodrome symptoms typi-
cally begin. Harrison (1999) has argued cogently that
key susceptibility genes (such as catechol-O-methyl-
transferase, neuregulin, dysbindin) converge toward
the risk of schizophrenia by their role in synaptic
plasticity/function (Frankle et al. 2003) so as to impair
higher order information processing. In other words,
this disorder appears, in its fundamental form, to
be one of impaired stabilization and development of
cortical micro-circuitry (Harrison, 1999 ; Winterer and
Weinberger, 2004). Consequently, the directionality of
neuroimaging findings in schizophrenia may be quite
difficult to predict, but DTI evidence for disruption
of white matter connections linked to a multiplicity
of symptoms fits with asynchronization of neural cir-
cuitry during neurodevelopment, resulting in synaptic
misconnections (Andreasen et al. 1999 ; Frankle et al.
2003 ; Whitefield-Gabrieli et al. 2009).
Strengths and weaknesses of study
The study involved a never-medicated, first-episode
group of patients with schizophrenia and aimed to
investigate how their symptoms are related to system
of white matter connectivity. It employed a voxel-
based approach not constrained by prior hypotheses.
Patients with schizophrenia were carefully diagnosed
and ethnically homogeneous and well balanced with
the healthy controls. Although missing data meant
that we were not able to enter the duration of un-
treated psychosis as a covariate to explore the possi-
bility of a relationship between duration of psychosis
and FA score, we observed that the duration of psy-
chosis for many subjects was approximately 1 year.
This is a potential limitation of the study, together
with the DTI sequence used, which could be improved
in power with thinner slices and a more powerful
magnet, which, fortunately, will become accessible to
our patients for future studies.
A between-group analysis followed by exploration
of symptom correlates of regions showing significant
differences would arguably have been the statistically
more powerful and conventional approach. However,
we previously published cross-sectional data on a
sample including many of the patients and controls
from the present study (Cheung et al. 2008). We con-
sidered that the regions uncovered in a cross-sectional
study might encompass aspects of the illness not
exclusively pertaining to symptoms, such as predis-
position/vulnerability to disorder. Therefore, since
the main thrust of the current study was to examine
the symptom–FA interaction, we decided to perform
whole-brain correlational analysis. As discussed ear-
lier, the FA correlates of positive symptoms coincided
with fewer than half the regions of group difference
identified in the cross-sectional analysis. We interpret
this finding as pointing towards a difference in the
white matter pathways contributing to more ‘static ’
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Fig. 3. Scatter plot of the relationship between functional anisotropy (FA) of significant temporal clusters with positive symptom
subscale on the Positive and Negative Syndrome Scale (PANSS). A best-fitted least square line was plotted for each of the five
frontal areas and their corresponding R2 given next to each of the best-fitted lines.
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disease traits responsible for group differences and
those that are involved in generation of positive
symptoms.
In conclusion, fronto-occipital and temporo-limbic
white matter connectivity positively correlates with
positive symptom scores in first-episode schizo-
phrenia. These effects on white matter connections are
not influenced by pharmacotherapy and therefore
appear to be disease-related. Future work will focus
on mapping the progression of illness using FA, to-
gether with other neuroimaging markers, to investi-
gate how the administration of antipsychotic agents
can modify brain structure and symptoms.
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